secwatch.observer — SEC 8-K summary
======================================

Issuer:     CapForce Inc. (CFOR)
CIK:        0001293818
Form:       8-K
Filed at:   2024-04-17T23:59:59+00:00
Accession:  0001829126-24-002584
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OpGen appoints David Lazar as CEO with deferred salary and concurrent CEO roles
-------------------------------------------------------------------------------

- David Lazar, age 33, appointed CEO effective April 1, 2024; also serves as Chairman of the Board.
- Base salary $406,000 per annum, fully deferred until Compensation Committee determines sufficient liquidity.
- Three-year term; Lazar concurrently serves as CEO of Titan Pharmaceuticals (TTNP) and Minim, Inc. (MINM).
- Annual bonus at 100% base salary; special bonus: 3% of change-in-control valuation increase, $203k per $1M+ capital raise.
- Severance includes salary continuation for 12 months or remaining term, medical reimbursement, prorated bonus, accelerated vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293818/000182912624002584/0001829126-24-002584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293818/000182912624002584/opgen_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-24-002584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer